Allergic Drug Reactions

Drugs alone do not provoke immune responses, but they combine with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. Upon re-exposure to the drug, antigen-antibody interactions trigger the release of mediators that produce allergic reactions affecting the skin, gastrointestinal tract, and respiratory systems.

IgE-type antibodies fix themselves to mast cells during the initial immune sensitization phase. When the drug is encountered again, antigen-antibody interactions occur on mast cell surfaces, liberating mediators that produce immediate type I allergic reactions. This mechanism explains the rapid onset of symptoms in IgE-mediated drug allergies.

Type II reactions involve IgG and IgM antibodies interacting with drug-altered host cells, activating the complement system. Type III reactions are mediated by antibodies bound to soluble antigens, called immune complexes, which also activate complement and stimulate mediator release. Both mechanisms produce inflammatory responses but target different antigen sources.

Type IV reactions do not involve antibodies; instead, they are mediated by activated T-cells that release cytokines. These cytokines recruit macrophages and neutrophils to generate inflammatory responses. This cell-mediated mechanism produces delayed-type hypersensitivity, distinguishing it from the immediate antibody-driven reactions of types I, II, and III.

Allergic drug reactions are hypersensitivity responses because they result from exaggerated immune system activity unrelated to the drug's therapeutic action. The immune system overreacts to drug-protein complexes, producing antibodies or T-cell responses that generate excessive inflammatory mediators and cause tissue damage rather than therapeutic benefit.

The complement system is activated in type II and type III drug hypersensitivity reactions. In type II reactions, complement activation occurs when IgG and IgM antibodies bind to drug-altered host cells. In type III reactions, immune complexes activate complement, prompting mediator release that triggers inflammatory responses characteristic of these allergic reactions.

Drug allergies represent one category of adverse effects within the broader spectrum of effects of chemicals overview. Understanding the immune mechanisms of allergic reactions helps distinguish them from toxic reactions, pharmacokinetic interactions, and other adverse effects, enabling healthcare providers to identify and manage drug-related complications appropriately.